Researchers at Cedars-Sinai have developed a fast, new technique for analyzing cells, described in the journal Angewandte ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
Ligand Pro, founded by Skoltech professors and a Skoltech Ph.D. student, has presented Matcha, an AI-powered molecular docking model that performs virtual drug screening 30 times faster than the large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results